Submission Details
Molecule(s):
C1=CC2N=C(c3cnc4ccccc4n3)OC2C=C1
Brc1ccc2oc(-c3cnc4ccccc4n3)nc2c1
Clc1nc2ccccc2cc1-c1nc2ccccc2o1
Clc1nc2ccccc2cc1-c1nc2cc(Br)ccc2o1
Fc1ccc2nc(Cl)c(-c3nc4cc(Br)ccc4o3)cc2c1
Clc1ccc2nc(Cl)c(-c3nc4cc(Br)ccc4o3)cc2c1
Clc1nc2ccc(Br)cc2cc1-c1nc2cc(Br)ccc2o1
O=[N+]([O-])c1ccc2nc(Cl)c(-c3nc4cc(Br)ccc4o3)cc2c1
O=[N+]([O-])c1cc(F)cc2cc(-c3nc4cc(Br)ccc4o3)c(Cl)nc12
O=[N+]([O-])c1cc(Cl)cc2cc(-c3nc4cc(Br)ccc4o3)c(Cl)nc12
O=[N+]([O-])c1cc(Br)cc2cc(-c3nc4cc(Br)ccc4o3)c(Cl)nc12
O=[N+]([O-])c1cc([N+](=O)[O-])c2nc(Cl)c(-c3nc4cc(Br)ccc4o3)cc2c1
Design Rationale:
Structural features seen of similar compounds exhibiting good biological activity (By eye)
Other Notes:
I am working in the field of medicinal chemistry in search of potential drug targets for infectious diseases such as tuberculosis, cancer, microbial infections etc. First time trying to work try compounds for target to treat viral disease.